A phase 1 trial and pharmacokinetic study of RRx-001, a novel ROS-mediated pan-epigenetic agent.
Tony R. Reid
No relevant relationships to disclose
Bryan Oronsky
Employment or Leadership Position - RadioRx
Consultant or Advisory Role - RadioRx (I,U); RadioRx (U)
Stock Ownership - RadioRx (I); RadioRx
Jeffrey R. Infante
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
Curtis Scribner
Consultant or Advisory Role - RadioRx
Susan Jane Knox
Consultant or Advisory Role - RadioRx
Stock Ownership - RadioRx
Honoraria - RadioRx
Research Funding - RadioRx
Janet L. Stephens
Employment or Leadership Position - RadioRx
Stock Ownership - RadioRx
Gary Fanger
Consultant or Advisory Role - RadioRx (U)
Jan Scicinski
Employment or Leadership Position - RadioRx
Stock Ownership - RadioRx